Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ARTIC
Sponsor

ARTIC

France 20 Rue Leblanc, 75015 Paris, France

About the sponsor

Research activity in kidney cancer focuses on metastatic renal cell carcinoma and treatment selection informed by molecular subgroups. The clinical interest includes immunotherapy with nivolumab and ipilimumab, as well as targeted therapy with tyrosine kinase inhibitors such as sunitinib and pazopanib.

  • Renal cell carcinoma
  • Immunotherapy
  • Targeted therapy
  • Molecular subgroup stratification

The sponsor’s work in this area is centered on comparing treatment approaches across biologically defined disease groups in advanced kidney malignancy.

About Specializations

ARTIC runs clinical trials in conditions such as Prostate cancer, Metastases to lymph nodes, Renal cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Prostate cancer+1

Recruiting

Study on Darolutamide, Triptorelin, and Leuprorelin Acetate for Patients with Newly Diagnosed Prostate Cancer and Pelvic Lymph Node Metastases

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:ARTIC

Renal cancer

Not yet recruiting

Study of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:ARTIC

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.